OCCURRENCE OF VENOUS THROMBOEMBOLISM AND OUTCOMES OF PREVENTIVE PROTOCOLS AT THE BANGKOK HOSPITAL MEDICAL CENTER: A RETROSPECTIVE REVIEW OF YEARS 2012-2013
Chotanaphuti T, Foojareonyos T, Panjapong S, et al. Incidence of deep vein thrombosis in postoperative hip fracture patients in Phramongkutklao Hospital. J Med Assoc Thai 2005;88 S159-63.
Pookarnjanamorakot C, Sirisriro R, Eurvilaichit C, et al. The incidence of deep vein thrombosis and pulmonary embolism after total knee arthroplasty:the screening study by radionuclide venography. J Med Assoc Thai 2004;87:869-76.
Chotanaphuti T, Ongnamthip P, Silpipat S, et al. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty. J Med Assoc Thai 2007;90:1342-7.
Chotanaphuthi T, Heebthamai D, Taweewuthisub W, et al . Prediction of deep vein thrombosis after total knee arthroplasty with preoperative D-dimer plasma measure-ment. J Med Assoc Thai 2009;92 Suppl 6:S6-10.
Niikura T, Lee SY, Oe K, et al. Venous thromboembolism in Japanese patients with fractures of the pelvis and/or lower extremities using physical prophylaxis alone. J Orthop Surg (Hong Kong) 2012;20:196-200.
Piovella F, Wang CJ, Lu H, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemio-logical study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost 2005;3:2664-70.
Leizorovicz A, Turpie AG, Cohen AT, et al. SMART Study Group. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study. J Thromb Haemost 2005;3:28-34.
Cohen A, Chiu KM, Park K, et al. Managing venous thromboembolism in Asia: winds of change in the era of new oral anticoagulants. Thromb Res 2012;130:291-301.
Pechevis M, Detournay B, Pribil C, et al. Economic evaluation of enoxaparin vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients. Value Health 2000;3:389-96.
Nuijten MJ, Villar FA, Kosa J, et al. Cost-effectiveness of enoxaparin as thromboprophylaxis in acutely ill medical patients in Spain. Value Health 2003;6:126-36.
Duff J, Walker K, Omari A, et al. Prevention of venous thromboembolism in hospitalized patients: analysis of reduced cost and improved clinical outcomes. J Vasc Nurs 2013;319-14.
Gussoni G, Foglia E, Frasson S, et al. Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients. Thromb Res 2013;131:17-23.
National Institute for Health and Clinical Excellence. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE clinical guideline. Accessed April 5, 2014, at http://www.nice.org.uk/CG092)
Tsai AW, Cushman M, Rosamond WD, et al. Cardiovas-cular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboem-bolism etiology. Arch Intern Med 2002;162:1182.
Folsom AR, Lutsey PL, Nambi V, et al. Troponin T, NT-proBNP, and venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Vasc Med 2014;19:33.
Van Schouwenburg IM, Mahmoodi BK, Gansevoort RT, et al. Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study. Thromb Haemost 2012;108:923.
Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008;117:93.
Zangari M, Anaissie E, Barlogie B, et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 2001; 98:1614-5.
Clahsen PC, van de Velde CJH, Julien JP, et al. Throm-boembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer/Breast Cancer Cooperative Group Study. J Clin Oncol 1994;12:1266-71.
Warlow C, Ogston D, Douglas AS. Venous thrombosis following strokes. Lancet 1972;1:1305-6.
Shojania KG, Duncan BW, McDonald KM, et al. Making health care safer: a critical analysis of patient safety practices. Report/Technology Assessment No. 43. Rock-ville, MD: Agency for Healthcare Research and Quality. (Accessed April 5, 2014, at www.ahrq.gov/clinic/pt-safety/).
Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: CHEST Evidence-Based Clinical Practice Guide- lines.
Jobin S, Kalliainen L, Adebayo L, et al. Venous thrombo-embolism prophylaxis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI) 2012:51.
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:381S-453S.
Lyman GH, Khorana AA, Kuderer NM, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2013;31:2189-204.
Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 2013;11:56-70.
Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Guidelines Committee. Guidelines for deep venous thrombosis prophylaxis during laparo-scopic surgery. Surg Endosc 2007;21:1007-9.